Trigonocephaly-bifid nose-acral anomalies syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3368OMIM:275595Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Trigonocephaly-bifid nose-acral anomalies syndrome (also known as Trigonocephaly syndrome, Say-Meyer type or Say-Meyer syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial and limb abnormalities. The condition is named for its three cardinal features: trigonocephaly (a triangular-shaped forehead caused by premature fusion of the metopic suture of the skull), a bifid nose (the nose appears split or notched at its tip), and acral anomalies (abnormalities of the hands and feet, including brachydactyly, syndactyly, or other digital malformations). Additional features may include intellectual disability, short stature, and other craniofacial dysmorphisms. The syndrome primarily affects the skeletal system (particularly the skull and extremities), the craniofacial structures, and potentially the central nervous system. Because of the premature cranial suture fusion, some affected individuals may experience increased intracranial pressure or developmental delays. The condition is present from birth, with the craniosynostosis and facial features typically apparent in the neonatal period. There is no specific cure or targeted therapy for this syndrome. Management is supportive and symptomatic, often involving a multidisciplinary team. Surgical correction of craniosynostosis may be necessary to relieve intracranial pressure and improve skull shape. Reconstructive surgery may be considered for the bifid nose and hand or foot anomalies. Developmental support and early intervention services are recommended for children with intellectual disability or developmental delays. Given the extreme rarity of this condition, only a handful of cases have been described in the medical literature, and long-term outcomes remain poorly characterized.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Trigonocephaly-bifid nose-acral anomalies syndrome.

View clinical trials →

No actively recruiting trials found for Trigonocephaly-bifid nose-acral anomalies syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Trigonocephaly-bifid nose-acral anomalies syndrome community →

No specialists are currently listed for Trigonocephaly-bifid nose-acral anomalies syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Trigonocephaly-bifid nose-acral anomalies syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Trigonocephaly-bifid nose-acral anomalies syndromeForum →

No community posts yet. Be the first to share your experience with Trigonocephaly-bifid nose-acral anomalies syndrome.

Start the conversation →

Latest news about Trigonocephaly-bifid nose-acral anomalies syndrome

No recent news articles for Trigonocephaly-bifid nose-acral anomalies syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Trigonocephaly-bifid nose-acral anomalies syndrome

What is Trigonocephaly-bifid nose-acral anomalies syndrome?

Trigonocephaly-bifid nose-acral anomalies syndrome (also known as Trigonocephaly syndrome, Say-Meyer type or Say-Meyer syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial and limb abnormalities. The condition is named for its three cardinal features: trigonocephaly (a triangular-shaped forehead caused by premature fusion of the metopic suture of the skull), a bifid nose (the nose appears split or notched at its tip), and acral anomalies (abnormalities of the hands and feet, including brachydactyly, syndactyly, or other digi

How is Trigonocephaly-bifid nose-acral anomalies syndrome inherited?

Trigonocephaly-bifid nose-acral anomalies syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Trigonocephaly-bifid nose-acral anomalies syndrome typically begin?

Typical onset of Trigonocephaly-bifid nose-acral anomalies syndrome is neonatal. Age of onset can vary across affected individuals.